USANA Health Sciences (USNA) Misses Q4 EPS by 1c, Revenues Miss; Offers FY EPS/Revenue Guidance Above Consensus

Go back to USANA Health Sciences (USNA) Misses Q4 EPS by 1c, Revenues Miss; Offers FY EPS/Revenue Guidance Above Consensus

USANA Health Sciences Reports Record Full-Year 2018 Results

February 5, 2019 4:17 PM EST

Record fiscal year net sales of $1.189 billion, an increase of 13.6% Record fiscal year net earnings of $126.2 million, or $5.12 per share Fourth quarter net sales of $299.0 million, an increase of 9.5% year-over-year Fourth quarter net earnings of $32.3 million, or $1.32 per share

SALT LAKE CITY--(BUSINESS WIRE)-- USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal fourth quarter and full-year ended December 29, 2018.

Financial Performance

Fourth quarter 2018 net sales... More